Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
4.210
+0.100 (2.43%)
At close: Sep 11, 2026, 4:00 PM EDT
4.050
-0.160 (-3.80%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Alterity Therapeutics Employees
Alterity Therapeutics had 11 employees as of June 30, 2026. The number of employees increased by 2 or 22.22% compared to the previous year.
Employees
11
Change (1Y)
2
Growth (1Y)
22.22%
Revenue / Employee
$227,038
Profits / Employee
-$1,471,712
Market Cap
72.09M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 11 | 2 | 22.22% |
| Jun 30, 2025 | 9 | -1 | -10.00% |
| Jun 30, 2024 | 10 | -1 | -9.09% |
| Jun 30, 2023 | 11 | -1 | -8.33% |
| Jun 30, 2022 | 12 | 1 | 9.09% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| Gossamer Bio | 162 |
| XBiotech | 87 |
| Pliant Therapeutics | 49 |
| NeurAxis | 24 |
| Gain Therapeutics | 21 |
| Cingulate | 14 |
| Nutriband | 13 |
ATHE News
- 19 hours ago - Alterity Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 8 days ago - Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026 - GlobeNewsWire
- 15 days ago - Alterity Therapeutics Annual report: H2 2026 - Filings
- 25 days ago - Alterity Therapeutics granted new patent for ATH434 - TheFly
- 4 weeks ago - Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434 - GlobeNewsWire
- 4 weeks ago - Alterity Therapeutics Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 4 weeks ago - Alterity Therapeutics (ATHE) Rated Buy by Craig-Hallum Amid Phase 3 Trial Optimism - GuruFocus
- 4 weeks ago - Craig-Hallum bullish on Alterity Therapeutics, initiates with a Buy - TheFly